BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30132167)

  • 1. [Biomarkers for thromboembolic events in patients with pancreatic adenocarcinoma].
    Felgendreff P; Rauchfuß F; Settmacher U
    Chirurg; 2018 Oct; 89(10):830. PubMed ID: 30132167
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple thromboembolic complications in pancreatic cancer].
    Protsenko NV; Andreev OV; Baunov VA
    Vopr Onkol; 1984; 30(11):89-91. PubMed ID: 6516264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biomarkers for thromboembolic events in patients with pancreatic adenocarcinoma].
    Felgendreff P; Rauchfuß F; Settmacher U
    Chirurg; 2019 Mar; 90(Suppl 2):61. PubMed ID: 30758606
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboembolism and anticoagulation in pancreatic cancer.
    Habib M; Saif MW
    JOP; 2013 Mar; 14(2):135-7. PubMed ID: 23474555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients.
    Shaib W; Deng Y; Zilterman D; Lundberg B; Saif MW
    Anticancer Res; 2010 Oct; 30(10):4261-4. PubMed ID: 21036750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic thrombocytopenic purpura in a newly diagnosed pancreatic adenocarcinoma.
    Bir A; Bshara W; George M; Fakih MG
    JOP; 2006 Nov; 7(6):647-50. PubMed ID: 17095846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.
    Santucci N; Facy O; Ortega-Deballon P; Lequeu JB; Rat P; Rat P
    Pancreatology; 2018 Sep; 18(6):666-670. PubMed ID: 30153902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum des-gamma-carboxyprothrombin in patients with pancreatic head adenocarcinoma.
    Kemik AS; Kemik O; Purisa S; Tuzun S
    Bratisl Lek Listy; 2011; 112(10):552-4. PubMed ID: 21954538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of tumor stage, symptoms, and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer.
    Porta M; Pumarega J; López T; Jariod M; Marco E; Grimalt JO;
    Cancer Causes Control; 2009 Dec; 20(10):1893-906. PubMed ID: 19562493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Embolizing nonbacterial thrombotic encocarditis in pancreatic carcinoma].
    Horváth A; Zuffa M; Lehotský E
    Bratisl Lek Listy; 1967 Feb; 47(3):169-74. PubMed ID: 6040724
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo.
    Stark K; Schubert I; Joshi U; Kilani B; Hoseinpour P; Thakur M; Grünauer P; Pfeiler S; Schmidergall T; Stockhausen S; Bäumer M; Chandraratne S; von Brühl ML; Lorenz M; Coletti R; Reese S; Laitinen I; Wörmann SM; Algül H; Bruns CJ; Ware J; Mackman N; Engelmann B; Massberg S
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):772-786. PubMed ID: 29419408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center.
    Pinzon R; Drewinko B; Trujillo JM; Guinee V; Giacco G
    J Clin Oncol; 1986 Apr; 4(4):509-14. PubMed ID: 3958764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: CA 19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and preoperative therapy.
    Bold RJ
    Ann Surg Oncol; 2013 Jul; 20(7):2108-10. PubMed ID: 23563959
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.
    Gasiorowska A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E
    Dig Dis Sci; 2016 Apr; 61(4):1121-9. PubMed ID: 26597191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenocarcinoma of the pancreas: are CA 19-9 assays useful?].
    Lévy P
    Presse Med; 2008 Jan; 37(1 Pt 2):88-94. PubMed ID: 17980545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic neoplasms and risk of thrombosis].
    Grosse H
    Dtsch Z Verdau Stoffwechselkr; 1979; 37(4):172-6. PubMed ID: 540562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colony stimulating factor producing carcinoma of the pancreas--a case report].
    Ohwada S; Miyamoto Y; Fujii T; Kuribara T; Teshigawara O; Oyama T; Ishii H; Joshita T; Izuo M
    Gan No Rinsho; 1989 Mar; 35(4):523-7. PubMed ID: 2469806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of Vitamin E levels in patients with pancreatic adenocarcinoma].
    Wang DF; Qu XC; Dai ZQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):210-1. PubMed ID: 12390764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
    Varol E
    Eur J Intern Med; 2014 Jul; 25(6):e82. PubMed ID: 24582330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.